Skip to Main Content

Paper Details

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.
Cancer Immunol Res
36
2020
B16, B16 melanoma, CTLA-4, Flt3 ligand, Melanoma, PD-1, PD-L1, T cells, T-cell, cancer, melanoma, patients, tumors
Author NameAffiliation
Shivanand PudakalakattiThe University of Texas MD Anderson Cancer Center
Prasanta DuttaThe University of Texas MD Anderson Cancer Center
Cristina IvanThe University of Texas MD Anderson Cancer Center
Zhenlin JuThe University of Texas MD Anderson Cancer Center
Michael A DaviesMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Michael A DaviesMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Jennifer A WargoMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Pratip BhattacharyaMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
Pratip BhattacharyaThe University of Texas MD Anderson Cancer Center
  • 1 - 12

Datasets

Release 1.2